A Study of Brief Behavioral Activation for the Treatment of Depression in Older Adult Cancer Survivors

ConditionSurvivorship
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age65+
SponsorMemorial Sloan Kettering Cancer Center

About this trial

The purpose of this study is to find out if a psychotherapy method called behavioral activation (BA) can be successfully delivered by telephone or videoconference (remotely) and can effectively treat depression in Older Adult Cancer Survivors (OACS)

Eligibility criteria

Qualifiers

As per self-report or medical record, ≥65 years old

As per self-report or medical record, has a history of cancer

a patient in MSK Survivorship Clinics AND/OR

no evidence of disease (NED) AND/OR

Disqualifiers

As per PI determination, requires a higher level of care for current passive or active suicidal ideation than current protocol is able to provide. If a participant receives a score of > 0 on item 9 of the PHQ-9, they will be referred to study PI for further evaluation. They will be excluded from participation in this study if the PI determines they would be appropriate for a higher level of care than BA may be able to provide.

As per self-report or as documented in the medical record, current untreated (e.g., no medication, no therapy) major psychotic disorder (schizotypal personality disorder, schizophreniform disorder, schizoaffective disorder). Patients diagnosed with a major psychiatric disorder will be reviewed by the study PI to determine eligibility prior to consent.

As per self-report or medical record, currently taking antidepressant medication for < 3 month

As per medical record, patient has impaired decision-making capacity

Trial design

Treatments tested in this trial

  • Behavioral Activation
  • Supportive Psychotherapy

Treatment groups

90 Participants
are divided into 2 treatment groups